Pharma Invest ApS — Credit Rating and Financial Key Figures
CVR number: 44073110
Stockholmsgade 45, 2100 København Ø
Income statement (kDKK)
2023 | |
|---|---|
| Fiscal period length | 12 |
| Net sales | |
| Gross profit | -45.43 |
| EBIT | -45.43 |
| Other financial income | 561.09 |
| Other financial expenses | - 106.36 |
| Pre-tax profit | 409.30 |
| Income taxes | -90.02 |
| Net earnings | 319.27 |
Assets (kDKK)
2023 | |
|---|---|
| Intangible assets total | |
| Tangible assets total | |
| Investments total | |
| Long term receivables total | |
| Inventories total | |
| Short term receivables total | |
| Other current investments | 9 808.74 |
| Cash and bank deposits | 37.14 |
| Cash and cash equivalents | 9 845.89 |
| Balance sheet total (assets) | 9 845.89 |
Equity and liabilities (kDKK)
2023 | |
|---|---|
| Share capital | 40.00 |
| Profit of the financial year | 319.27 |
| Shareholders equity total | 359.27 |
| Non-current liabilities total | |
| Short-term deferred tax liabilities | 90.02 |
| Other non-interest bearing current liabilities | 9 396.59 |
| Current liabilities total | 9 486.61 |
| Balance sheet total (liabilities) | 9 845.89 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.